MedTrace Logo

Evaluation of the Effect of Garcinia in Combination With Chromium on the Clinical Outcomes of Patients With LUTS/BPH

NCT04590534 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2022-11-10

No results posted yet for this study

Summary

To evaluate efficacy and safety of garcinia extract + chromium combinations (Chromax) in symptomatic benign prostatic hypertrophy patients

Conditions

  • Prostatic Hyperplasia

Interventions

DRUG

Chromax

Treatment of BPH by Chromax for 3 Months

DRUG

Sildosin Group

patients will receive one capsule of Sidosin 8 mg once daily for 12 weeks

OTHER

Placebo Group

patients will receive placebo 3 times daily for 12 weeks

Sponsors & Collaborators

  • Benha University

    lead OTHER

Principal Investigators

  • Waleed El-Shaer, M.D · Banha Univesity

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2023-02-01
Completion
2023-03-12

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04590534 on ClinicalTrials.gov